Efficacy of enrofloxacin for the treatment of experimentally induced Ehrlichia canis infection.
Neer
T M
TM
Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Louisiana State University, Baton Rouge 70803, USA.
Eddlestone
S M
SM
Gaunt
S D
SD
Corstvet
R E
RE
D000818:Animals; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D000907:Antibodies, Bacterial / Q000097:blood; D004269:DNA, Bacterial / Q000097:blood; D004283:Dog Diseases / Q000188:drug therapy*; D004285:Dogs; D004536:Ehrlichia / Q000235:genetics / Q000276:immunology / Q000502:physiology*; D016873:Ehrlichiosis / Q000188:drug therapy / Q000662:veterinary*; D000077422:Enrofloxacin; D005455:Fluorescent Antibody Technique / Q000662:veterinary; D024841:Fluoroquinolones; D016133:Polymerase Chain Reaction / Q000662:veterinary; D015363:Quinolones / Q000627:therapeutic use*; D017211:Treatment Failure
D000890:Anti-Infective Agents; D000907:Antibodies, Bacterial; D004269:DNA, Bacterial; D024841:Fluoroquinolones; D015363:Quinolones; D000077422:Enrofloxacin